CTRI/2017/07/009111已完成未知
Effect of Nishamlaki in patients of Polycystic Ovarian Syndrome
Pharmaza Herbals Pvt Ltd0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •females diagnosed with polycystic ovarian syndrome
排除标准
- •patients with
- •1.known liver,kidney,heart disease
- •2.complaining of infertility
- •3.active infection such as HIV, tuberculosis,hepatitis,etc
- •4.assosiated cervical and/or uterine pathologies like fibroid,polyp, endometriosis,etc
- •5.congenital anamolies related to genital tract
- •6.other endocrinal abnormalities
研究者
相似试验
尚未招募
不适用
Effect of unani medicine in the treatment of Polycystic Ovarian disease. An open Observational studyCTRI/2021/02/031070ational Institute of Unani Medicine
进行中（未招募）
不适用
POLICYSTIC OVARIAN SYNDROME AND NITRIC OXIDE. EFFECTS OF TREATMENT WITH N-ACETYLCYSTEINE AND ARGININETO RESTORE A PHYSIOLOGICAL MESTRUAL CICLICITY AND OVULATION INCREASING THE PRODUCTION OF NITRIC OXIDE IN SUBJECTS WITH POLICYSTIC OVARIAN SYNDROME BY MEANS OF ARGININE AND ACETYLCYSTEINE ADMINISTRATIONMedDRA version: 9.1Level: LLTClassification code 10036049Term: Polycystic ovariesEUCTR2005-002091-15-ITAZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
尚未招募
1 期
To see the effect if vamana karma in poly cystic ovarian syndrome(artava kashya)CTRI/2022/07/044169Patanjali bhartiya aayurvigyaan evum anusandhan sansthaan haridwar
尚未招募
2 期
Benefits of Sharbat Afsanteen in Poly Cystic Ovarian DiseaseCTRI/2019/03/017970ational Institute of Unani Medicine
尚未招募
不适用
Role of inflammation (body response to noxious environmental agents) in Indian women with Polycystic ovary syndrome (PCOS- a disorder characterized by menstrual abnormalities, unwanted hair growth, infertility etc.) and its modulation by dietary factorsCTRI/2013/09/003996AIIMS New Delhi210